RA
PAVM icon

RFG Advisory’s PAVmed PAVM Stock Holding History

RFG Advisory’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-238
Closed -$31.5K – 676
2023
Q3 		$31.5K Hold
238
– – ﹤0.01% 619
2023
Q2 		$43.6K Hold
238
– – ﹤0.01% 626
2023
Q1 		$40K Hold
238
– – ﹤0.01% 624
2022
Q4 		$54.8K Sell
238
-30
-11% -$11.3K ﹤0.01% 604
2022
Q3 		$125K Hold
268
– – 0.01% 593
2022
Q2 		$239K Sell
268
-19
-7% -$9.18K 0.01% 505
2022
Q1 		$170K Buy
287
+61
+27% +$45.3K 0.01% 494
2021
Q4 		$250K Sell
226
-167
-42% -$363K 0.02% 426
2021
Q3 		$1.51M Buy
393
+195
+98% +$615K 0.12% 123
2021
Q2 		$569K Buy
198
+38
+24% +$89.8K 0.05% 249
2021
Q1 		$319K Buy
+160
New +$241K 0.03% 334

Other funds holding PAVM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
XF
XML Financial Bethesda, Maryland $1.24B AUM 20.4% 1-Year Est. Return

RFG Advisory's PAVM Position: Q4 2023 in Review

RFG Advisory sold out of PAVmed (PAVM) in Q4 2023, closing a stake of 238 shares — an estimated $31.5K sold.

RFG Advisory first reported a position in PAVM in Q1 2021 and held it in 11 quarters. The position peaked at $1.51M in Q3 2021. 23 funds tracked by Wall St. Rank hold PAVM as of Q4 2023.

  • RFG Advisory reported no remaining PAVmed position as of Q4 2023 after selling out during the quarter.
  • RFG Advisory sold 238 PAVmed shares in Q4 2023, an estimated $31.5K.
  • RFG Advisory first reported a position in PAVmed in Q1 2021 and held it in 11 quarters.
  • RFG Advisory's PAVmed position peaked at $1.51M in Q3 2021.
  • 23 funds tracked by Wall St. Rank held PAVmed as of Q4 2023.

Based on RFG Advisory's 13F filing for Q4 2023, filed 25 Jan 2024.